The Bigger Picture Ozempic, Wegovy, Mounjaro, and Zepbound are not replacing your DMARDs or your biologics
Woo JS, Kim W, Ha SJ, Kim JB, Kim SJ, Kim WS, Seon HJ, Kim KS: Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study
Four trial participants required gallbladder removal surgery
Additionally, exenatide increased cerebral glucose metabolism in regions associated with glucose homeostasis, appetite, and food reward, as observed through [(18)F]2-fluoro-2-deoxy-d-glucose PET/CT scans [17,18,19]
EMERGING RISK SIGNALS A recent analysis published in The British Medical Journal (BMJ) Medicine has found that patients who discontinue GLP-1 therapies may face increased cardiovascular risks